Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.

BMC pediatrics - 1 Oct 2024

Zhou Qiong, Chao Yun-Qi, Dai Yang-Li, Gao Ying, Shen Zheng, Dong Guan-Ping, Zou Chao-Chun

Abstract excerpt

BACKGROUND: Prader-Willi syndrome (PWS) is a rare multisystemic hereditary illness. Recombinant human growth hormone (rhGH) therapy is widely recognized as the primary treatment for PWS. This study aimed to examine how different PWS genotypes influence the outcome of rhGH treatment in children with PWS. METHODS: A review was conducted on 146 Chinese children with PWS, genetically classified and monitored from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Human Growth Hormone
Share to Hypothyroidism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to Insulin-Like Growth Factor I

Share to Insulin Resistance

Share to Prader-Willi Syndrome

Share to Recombinant Proteins

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 39354420
DOI: 10.1186/s12887-024-05109-y
PMCID: PMC11443654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.PMID 39354420Read ↗

Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi SyndromeSemantic proximity Read ↗

Noonan syndrome: rhGH treatment and PTPN11 mutation.Semantic proximity Read ↗

Influence of molecular classes and growth hormone treatment on growth and dysmorphology in Prader-Willi syndrome: A multicenter study.Semantic proximity Read ↗

Schaaf-Yang Syndrome: Clinical Phenotype and Effects of 4 years of Growth Hormone Treatment.Semantic proximity Read ↗

Prader Willi syndrome: advances in genetics.Semantic proximity Read ↗

Genetic subtypes and phenotypic characteristics of 110 patients with Prader-Willi syndrome.Semantic proximity Read ↗

[Analysis of differences in clinical and biochemical characteristics and treatment effects in patients with different genotypes of Prader-Willi syndrome].Semantic proximity Read ↗

Growth Hormone Treatment in Patients With KBG Syndrome: Novel Insights, Challenges and Recommendations From Six New Patients and Literature Review.Semantic proximity Read ↗

Clinical features, genetic detection and therapeutic response to rhGH of children with Noonan syndrome: an analysis of 12 cases.Semantic proximity Read ↗

Effects of Growth Hormone Therapy on Sleep-Disordered Breathing and Metabolic Parameters in Patients with Prader–Willi Syndrome According to Genetic SubtypeSemantic proximity Read ↗

Molecular subtype and growth hormone effects on dysmorphology in Prader-Willi syndrome.Semantic proximity Read ↗

Genetic causes and treatment of isolated growth hormone deficiency-an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.